Atropine (atropine sulfate) NDC 60219-1748

NDC codes

FDA NDC Directory

Product NDC (as listed)60219-1748Labeler and product segments. Claims need a package NDC.

Product NDC at billing width60219-1748Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
60219-1748-2	60219174802	1 BOTTLE, DROPPER in 1 CARTON (60219-1748-2) / 2 mL in 1 BOTTLE, DROPPERMarketed from Jul 19, 2022

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Atropine
Generic name (nonproprietary): atropine sulfate
Active ingredients: Atropine sulfate — 10 mg/mL
Dosage form: Solution/ drops
Route: Ophthalmic
Labeler: Amneal Pharmaceuticals NY LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214752
Marketing start: Jul 19, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Cholinergic Antagonists (Mechanism)Cholinergic Muscarinic Antagonists (Mechanism)
Identifiers: Product ID 60219-1748_1b2b68ed-bad1-4742-b88d-1d2f0040ad52SPL ID 1b2b68ed-bad1-4742-b88d-1d2f0040ad52SPL set ID f8718be5-8fa4-4c36-a4fd-fac7c3953f5aRxCUI 1190655UNII 03J5ZE7KA5
Pharmacologic class: Anticholinergic; Cholinergic Muscarinic Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N460219174802 followed by a unit qualifier and the quantity

Package 60219-1748-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 4, 2025.

Indications (excerpt from the label)

Atropine sulfate ophthalmic solution, 1% is indicated in adults and pediatric patients aged three (3) months and older for: Atropine is an anticholinergic indicated in adults and pediatric patients aged three (3) months and older for: Cycloplegia ( 1.1 ) Mydriasis ( 1.2 ) Penalization of the healthy eye in the treatment of amblyopia. ( 1.3 ) 1.1 Cycloplegia 1.2 Mydriasis 1.3 Penalization of the Healthy Eye in the Treatment of Amblyopia

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 214752

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 214752
Product	Strength	Form · route	Labeler	Product NDC
Atropineatropine sulfate	Atropine sulfate 10 mg/mL	Solution/ dropsOphthalmic	Amneal Pharmaceuticals NY LLC	60219-1749
Atropineatropine sulfate	Atropine sulfate 10 mg/mL	Solution/ dropsOphthalmic	Amneal Pharmaceuticals NY LLC	60219-1750
Atropineatropine sulfate	Atropine sulfate 10 mg/mL	Solution/ dropsOphthalmic	A-S Medication Solutions	50090-7313